145 related articles for article (PubMed ID: 35952760)
1. Development, structure, and mechanism of synthetic antibodies that target claudin and Clostridium perfringens enterotoxin complexes.
Orlando BJ; Dominik PK; Roy S; Ogbu CP; Erramilli SK; Kossiakoff AA; Vecchio AJ
J Biol Chem; 2022 Sep; 298(9):102357. PubMed ID: 35952760
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for
Vecchio AJ; Rathnayake SS; Stroud RM
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM structures of a synthetic antibody against 22 kDa claudin-4 reveal its complex with
Erramilli SK; Dominik PK; Ogbu CP; Kossiakoff AA; Vecchio AJ
bioRxiv; 2023 Jun; ():. PubMed ID: 37398044
[TBL] [Abstract][Full Text] [Related]
4. Structural and biophysical insights into targeting of claudin-4 by a synthetic antibody fragment.
Erramilli SK; Dominik PK; Ogbu CP; Kossiakoff AA; Vecchio AJ
Commun Biol; 2024 Jun; 7(1):733. PubMed ID: 38886509
[TBL] [Abstract][Full Text] [Related]
5. On the interaction of Clostridium perfringens enterotoxin with claudins.
Veshnyakova A; Protze J; Rossa J; Blasig IE; Krause G; Piontek J
Toxins (Basel); 2010 Jun; 2(6):1336-56. PubMed ID: 22069641
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis of
Ogbu CP; Kapoor S; Vecchio AJ
Toxins (Basel); 2023 Oct; 15(11):. PubMed ID: 37999500
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins.
Veshnyakova A; Piontek J; Protze J; Waziri N; Heise I; Krause G
J Biol Chem; 2012 Jan; 287(3):1698-708. PubMed ID: 22128179
[TBL] [Abstract][Full Text] [Related]
8. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
9. Disruption of Claudin-Made Tight Junction Barriers by
Ogbu CP; Roy S; Vecchio AJ
Cells; 2022 Mar; 11(5):. PubMed ID: 35269525
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
[TBL] [Abstract][Full Text] [Related]
11. Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown.
Vecchio AJ; Stroud RM
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17817-17824. PubMed ID: 31434788
[TBL] [Abstract][Full Text] [Related]
12. Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.
Yelland TS; Naylor CE; Bagoban T; Savva CG; Moss DS; McClane BA; Blasig IE; Popoff M; Basak AK
J Mol Biol; 2014 Sep; 426(18):3134-3147. PubMed ID: 25020226
[TBL] [Abstract][Full Text] [Related]
13. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
14. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.
Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G
Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221
[TBL] [Abstract][Full Text] [Related]
15. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
English DP; Santin AD
Int J Mol Sci; 2013 May; 14(5):10412-37. PubMed ID: 23685873
[TBL] [Abstract][Full Text] [Related]
16. A cCPE-based xenon biosensor for magnetic resonance imaging of claudin-expressing cells.
Piontek A; Witte C; May Rose H; Eichner M; Protze J; Krause G; Piontek J; Schröder L
Ann N Y Acad Sci; 2017 Jun; 1397(1):195-208. PubMed ID: 28636798
[TBL] [Abstract][Full Text] [Related]
17. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
19. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.
Robertson SL; Smedley JG; McClane BA
Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339
[TBL] [Abstract][Full Text] [Related]
20. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
Shrestha A; McClane BA
mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
